1-4 of 4
Bola Hanna
Close
Sort by
Journal Articles

PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia

Fabienne McClanahan, Bola Hanna, Shaun Miller, Andrew James Clear, Peter Lichter, John G. Gribben, Martina Seiffert
Journal: Blood
Blood (2015) 126 (2): 203–211.
https://doi.org/10.1182/blood-2015-01-622936
Published: 2015
Includes: Supplemental data
Journal Articles

Targeting Dysfunctional Myeloid Cells Delays Disease Development and Improves Immune Function in a CLL Mouse Model

Bola Hanna, Fabienne McClanahan, MD, Nadja Zaborsky, PhD, Claudia Dürr, Verena Kalter, Alexander Egle, MD, John G. Gribben, MD DSc, Peter Lichter, PhD, Martina Seiffert, PhD
Journal: Blood
Blood (2014) 124 (21): 3298.
https://doi.org/10.1182/blood.V124.21.3298.3298
Published: 2014
Journal Articles

Immune Checkpoint Blockade with Anti-PD-L1 Prevents Immune Dysfuntion and CLL Development in the TCL1 Adoptive Transfer Mouse Model

Bola Hanna, Fabienne McClanahan, MD, Andrew James Clear, BSc, Shaun Miller, Peter Lichter, PhD, Martina Seiffert, PhD, John G. Gribben, MD DSc
Journal: Blood
Blood (2014) 124 (21): 717.
https://doi.org/10.1182/blood.V124.21.717.717
Published: 2014
Journal Articles

The Flavonoid Wogonin Reduces CLL Cell Survival in Vitro and Leukemia Development in Eµ-TCL1 Mice By Targeting Aberrant TNF Receptor Signaling

Claudia Dürr, Bola Hanna, Fabienne McClanahan, MD, Andrew James Clear, BSc, Thorsten Zenz, MD, Stephan Stilgenbauer, MD, John G. Gribben, MD DSc, Peter Lichter, PhD, Martina Seiffert, PhD
Journal: Blood
Blood (2014) 124 (21): 1966.
https://doi.org/10.1182/blood.V124.21.1966.1966
Published: 2014